Medical Advocates
HCV Infection/Disease
  National Seroprevalence/Incidence Studies/
National Challenges
Global                            Russia/NIS
Africa   
Asia
Australia/Pacific Islands
 Europe          
Latin America/Caribbean 
Middle East
North America








 
HCV Main Page Main New/Newsworthy  Home Page      
Last Update:  April 25, 2018
Documents identified with this icon are in Portable Document Format (PDF) and require the Adobe Acrobat Reader
Global
 
     Journal Papers, Abstracts, and Commentaries
 
 

Global Epidemiology of HCV Subtypes and Resistance-associated Substitutions Evaluated by Sequencing-Based Subtype Analyses.
Welzel T, Bhardwaj N, Hedskog C,  et al
 J Hepatol. 2017 Mar 23.
 Abstract

Hepatitis C virus seroprevalence in the general female population of 9 countries in Europe, Asia and Africa.
Clifford GM, Waterboer T, Dondog B,  et al
 Infect Agent Cancer. 2017 Feb 2;12:
 Abstract

Hepatitis C: Global Epidemiology and Strategies for Control.
 Lanini S, Easterbrook PJ, Zumla A, Ippolito G.
 Clin Microbiol Infect. 2016 Aug 10.
Abstract

Potential market size and impact of hepatitis C treatment in low- and middle-income countries.
 Woode ME, Abu-Zaineh M, Perriëns J, et al   
 J Viral Hepat. 2016 Feb 29
 Abstract

Universal screening for chronic hepatitis C virus.
Shiffman ML.
 Liver Int. 2016 Jan;36 Suppl 1:62-6.
Abstract

FULL-TEXT ARTICLE
 A Public Health Approach to Hepatitis C Control in Low- and Middle-Income Countries.
 Suthar AB, Harries AD.
PLoS Med. 2015 Mar 10;12(3):e1001795.
 Paper

FULL-TEXT ARTICLE
Chronic hepatitis C genotype 1 treatment roadmap for resource constrained settings.
 Lim SG.
World J Gastroenterol. 2015 Feb 14;21(6):1972-81.
 Paper

Estimates on HCV disease burden worldwide – filling the gaps.
 Wedemeyer H, Dore GJ, Ward JW.
 J Viral Hepat. 2015 Jan;22 Suppl 1:1-5.
 Abstract

The present and future disease burden of hepatitis C virus (HCV) infections with today’s treatment paradigm – volume 2.
 Hatzakis A, Chulanov V, Gadano AC, et al
J Viral Hepat. 2015 Jan;22 Suppl 1:26-45.
 Abstract

A Path to Eradication of Hepatitis C in Low-and Middle-Income Countries.
 Graham CS, Swan T.
Antiviral Res. 2015 Jan 20. pii: S0166-3542(15)00005-
 Abstract

Study identifies hepatitis C virus genotype 1 as the most prevalent worldwide.
 [No authors listed] 
Nurs Stand. 2014 Aug 13;28(50):17.
Abstract

Historical epidemiology of hepatitis C virus (HCV) in selected countries.
 Bruggmann P, Berg T, Ovrehus AL, et al
J Viral Hepat. 2014 May;21 Suppl 1:5-33.
Abstract

Minimum costs for producing Hepatitis C Direct Acting Antivirals, for use in large-scale treatment access programs in developing countries.
 Hill A, Khoo S, Fortunak J, et al
Clin Infect Dis. 2014 Jan 6.
 Abstract

FULL-TEXT ARTICLE
 Hepatitis C virus in Arab world: a state of concern.
 Daw MA, Dau AA.
ScientificWorldJournal. 2012;2012:719494.
 Paper
 
Expanding Access to Treatment for Hepatitis C in Resource-Limited Settings: Lessons From HIV/AIDS.
 Ford N, Singh K, Cooke GS,  et al
Clin Infect Dis. 2012 Mar 19.
Abstract

 
       Conference Reports, Abstracts, and Posters
 
  POSTER
 Structural level interventions to increase needle/syringe access for preventing HIV and hepatitis C among people who inject drugs in low- and middle-income countries:
an international systematic review
D.C. Des Jarlais, J. Feelemyer, S. Modi, H. Hagan
 (XIX International AIDS Conference)
Poster     Abstract
Africa
 
Multinational/Regional
 
     Journal Papers, Abstracts, and Commentaries
 
  Hepatitis C seroprevalence and HIV co-infection in sub-Saharan Africa: a systematic review and meta-analysis.
Rao VB, Johari N, du Cros P,  et al
 Lancet Infect Dis. 2015 May 5.
 Abstract
 		  
Côte d’Ivoire
 
     Journal Papers, Abstracts, and Commentaries
 
  Intra-host diversity and evolution of hepatitis C virus endemic to Côte d’Ivoire.
Forbi JC, Campo DS, Purdy MA, et al 
J Med Virol. 2014 May;86(5):765-71.
Abstract		  

DR Congo
 
     Journal Papers, Abstracts, and Commentaries
 
Hepatitis C Virus Genotype 7: A New Genotype Originating from Central Africa.
Murphy DG, Sablon E, Chamberland J,  et al
J Clin Microbiol. 2014 Dec 17.
Abstract		  

Egypt
 
     Journal Papers, Abstracts, and Commentaries
 
 
National treatment programme of hepatitis C in Egypt: Hepatitis C virus model of care.
 El-Akel W, El-Sayed MH, El Kassas M, et al
 J Viral Hepat. 2017 Feb 1.
 Abstract 

The prevalence of HCV infection in Egypt 2015: Implications for future policy on prevention and treatment.
Kandeel A, Genedy M, El-Refai S, et al
 Liver Int. 2016 Jun 8.
Abstract 

Female Sex Hormones Pattern and Its Relation to Disease Severity and Treatment in Pre- and Postmenopausal Patients with Chronic Hepatitis C Virus (Genotype 4) Infection.
Ahmed NH, El-Abaseri TB, El-Sayed HF, El-Serafi TI.
Int J Chronic Dis. 2015;2015:927974|
 Abstract 

Economic burden of hepatitis C in Egypt: the future impact of highly effective therapies.
Estes C, Abdel-Kareem M, Abdel-Razek W, et al
Aliment Pharmacol Ther. 2015 Jul 22
 Abstract

Reliability of Risk-Based Screening for Hepatitis C Virus Infection Among Pregnant Women in Egypt.
El-Kamary SS, Hashem M, Saleh DA,
J Infect. 2015 Jan 23. pii: S0163-4453(15)00030-4
 Abstract
Insulin resistance as a predictor of early virologic response to HCV therapy among chronic HCV Egyptian Patients.
Abd El-Wahab EW, Mikheal A,  et al 
J Med Virol. 2015 Jan 12.
Abstract

FULL-TEXT ARTICLE
 Circulating microRNA, miR-122 and miR-221 signature in Egyptian patients with chronic hepatitis C related hepatocellular carcinoma.
 El-Garem H, Ammer A, Shehab H, et al.
World J Hepatol. 2014 Nov 27;6(11):818-824.
 Paper

Hepatitis C virus acquisition among Egyptians: analysis of a 10-year surveillance of acute hepatitis C.
 Mohsen A, Bernier A, LeFouler L,  et al
Trop Med Int Health. 2014 Oct 22.
Abstract

A Polymorphism in the Microsomal Triglyceride Transfer Protein Can Predict the Response to Antiviral Therapy in Egyptian Patients with Chronic Hepatitis C Virus Genotype 4 Infection.
Saad Y, Shaker O, Nassar Y,  et al
Gut Liver. 2014 Oct 7.
Abstract

A comprehensive hepatitis C virus risk factors meta-analysis (1989-2013); Do they differ in Egypt?
El-Ghitany EM, Wahab MA, Wahab EW, et al
Liver Int. 2014 Jun 12
 Abstract

FULL TEXT ARTICLE
The Association between Female Genital Cutting and Spousal HCV Infection in Egypt.
 Kenyon CR, Colebunders R.
Int J Hepatol. 2014;2014:164357.
Paper

Effectiveness and cost-effectiveness of immediate vs. delayed treatment of HCV-infected patients in a country with limited resources:
the case of Egypt.
 Obach D, Deuffic-Burban S, Esmat G,  et al
Clin Infect Dis. 2014 Feb 7.
 Abstract

FULL-TEXT ARTICLE
 The epidemiology of hepatitis C virus in Egypt: a systematic review and data synthesis.
 Mohamoud YA, Mumtaz GR, Riome S, et al
BMC Infect Dis. 2013 Jun 24;13(1):288.
 Paper

Updates of Lifetime Costs of Care and Quality of Life Estimates for HIV-Infected Persons in the United States: Late Versus Early Diagnosis and Entry into Care.
Farnham PG, Gopalappa C, Sansom SL, et al
 J Acquir Immune Defic Syndr. 2013 Apr 22
 Abstract

HCV burden of infection in Egypt: results from a nationwide survey.
Guerra J, Garenne M, Mohamed MK, Fontanet A. et al
 J Viral Hepat. 2012 Aug;19(8):560-7
 Abstract

A systematic review of hepatitis C virus epidemiology in Asia, Australia and Egypt.
Sievert W, Altraif I, Razavi HA, et al
Liver Int. 2011 Jul;31 Suppl 2:61-80.
Abstract

Is the hepatitis C virus epidemic over in Egypt? Incidence and risk factors of new hepatitis C virus infections.
Mostafa A, Taylor SM, El-Daly M, et al
Liver Int. 2010 Jan 29.
Abstract

 
     Videos
 
Epidemiology of HCV in Egypt

 

Ghana

     Journal Papers, Abstracts, and Commentaries
 
  FULL-TEXT ARTICLE
 Epidemiology of hepatitis C virus in Ghana: a systematic review and meta-analysis.
 Agyeman AA, Ofori-Asenso R, Mprah A, Ashiagbor G.
BMC Infect Dis. 2016 Aug 9;16:391.
 Paper

   
Kenya
 
     Conference Reports, Abstracts, and Posters
 
  Social networks, risk factors and prevalence of HIV, HBV and HCV among drug users in Kenya
M.O. Oyaro, J. Wylie
 (XIX International AIDS Conference)
Abstract

Madagascar
 
     Journal Papers, Abstracts, and Commentaries
 
  Prevalence and trends of hepatitis C virus among blood donors in Antananarivo, from 2003 to 2009.
Randriamanantany ZA, Rajaonatahina DH, Razafimanantsoa FE, et al
Transfus Clin Biol. 2012 Mar 10.
Abstract
 
Morocco
 
     Journal Papers, Abstracts, and Commentaries
 
  The complete title: The effect of interleukin-28B rs12979860 polymorphism on the therapeutic response of Moroccan patients with chronic hepatitis C.
Nadia K, Hicham E, Reda TM,  et al
Gene. 2015 May 7.
Abstract		  

Nigeria
 
     Journal Papers, Abstracts, and Commentaries
 
  Epidemic history of hepatitis C virus infection in two remote communities in Nigeria, West Africa.
Forbi JC, Purdy MA, Campo DS,  et al
J Gen Virol. 2012 Mar 28
Abstract

Urban-rural estimation of hepatitis C virus infection sero-prevalence in north Central Nigeria.
Forbi JC, Pietzsch J, Olaleye VO,  et al
East Afr J Public Health. 2010 Dec;7(4):367-8.
 Abstract
 
Ethiopia

      Journal Papers, Abstracts, and Commentaries
 
  Prevalence and risk factors of Hepatitis C among individuals presenting to HIV testing centers, Hawassa city, Southern Ethiopia.
Alemayehu A, Tassachew Y, Sisay Z, Shimelis T.
BMC Res Notes. 2011 Jun 15;4(1):193.
Abstract
 
Rwanda

      Journal Papers, Abstracts, and Commentaries
 
  FULL-TEXT ARTICLE
Waiting for DAAs": A retrospective chart review of patients with untreated hepatitis C in Rwanda.
Gupta N, Kabahizi J, Mukabatsinda C,  et al;
 PLoS One. 2017 Mar 21;12(3):e0174148.
 Paper

South Africa
 
     Journal Papers, Abstracts, and Commentaries
 
  Introduction of new subtypes and variants of hepatitis C virus genotype 4 in South Africa.
Gededzha MP, Selabe SG, Kyaw T, et al 
J Med Virol. 2012 Apr;84(4):601-7.
 Abstract

 
Tanzania
 
      Conference Reports, Abstracts, and Posters
 
  Risk factors associated with HCV infection and prevalence of HIV-HCV co-infection among people who inject drugs receiving medication-assisted treatment in
Dar es Salaam, Tanzania
O. Chang, R.D. Bruce, F. Masao, et al
 (XX International AIDS Conference)
Abstract

Uganda
 
      Journal Papers, Abstracts, and Commentaries
 
  FULL-TEXT ARTICLE
 Serum adiponectin in HIV-1 and hepatitis C virus mono- and co-infected Kenyan injection drug users
 Ndombi EM, Budambula V, Webale MK,  et al 
Endocr Connect. 2015 Aug 25.
Paper

Medicinal plants used in malaria treatment by Prometra herbalists in Uganda.
 Adia MM, Anywar G, Byamukama R,  et al
J Ethnopharmacol. 2014 Jun 11.
Abstract

Asia
 
Regional/Multinational
 
     Journal Papers, Abstracts, and Commentaries
 
  Urgency to treat patients with chronic hepatitis C in Asia.
 Kao JH, Ahn SH, Chien RN,
J Gastroenterol Hepatol. 2016 Dec 22
 Abstract

FULL-TEXT ARTICLE
 Glucose abnormalities in Asian patients with chronic hepatitis C.
 Bo Q, Orsenigo R, Wang J, et al
Drug Des Devel Ther. 2015 Nov 9;9:6009-6017.
 Paper

FULL-TEXT ARTICLE
 A 2015 roadmap for the management of hepatitis C virus infections in Asia.
Lim SG, Dan YY. et al
Korean J Intern Med. 2015 Jul;30(4):423-433
 Paper

FULL-TEXT ARTICLE
 Genotypic distribution of hepatitis C virus in Thailand and southeast Asia.
 Wasitthankasem R, Vongpunsawad S, Siripon N, et al
PLoS One. 2015 May 11;10(5):e0126764.
Paper

Features of hepatitis C virus infection, current therapies and ongoing clinical trials in ten Asian Pacific countries.
Omata M, Kanda T, Yokosuka O,  et al
 Hepatol Int. 2015 May 5.
 Abstract

A systematic review of hepatitis C virus epidemiology in Asia, Australia and Egypt.
Sievert W, Altraif I, Razavi HA, et al
Liver Int. 2011 Jul;31 Suppl 2:61-80.
Abstract

China

      Journal Papers, Abstracts, and Commentaries
 
 
Molecular evolution of hepatitis C virus in China: A nationwide study.
Huang K, Chen J, Xu R,
 Virology. 2018 Feb 1;516:210-218
 Abstract

FULL-TEXT ARTICLE
Prevalence of hepatitis C virus infection and its correlates in a rural area of southwestern China: a community-based cross-sectional study.
Cheng W, Yang Y, Zhou Y,et al
 BMJ Open. 2017 Aug 11;7(8):e015717.
Paper

Temporal Changes in the Modes of Hepatitis C Virus Transmission in the USA and Northern China.
Wu E, Yang M, Rao H, et al
 Dig Dis Sci. 2017 Jun 1.
 Abstract

Prevalence of Occult Hepatitis C Virus Infection among Blood Donors in Jiangsu, China.
Lin H, Chen X, Zhu S, et al
 Intervirology. 2017 Feb 17;59(4):204-210.
 Abstract

Comparison of genotypes of hepatitis C virus between Chinese and Burmese drug users living in Dehong Prefecture, Yunnan Province.
 Wang YK, Feng KD, Wang JB, et al
 Zhonghua Yu Fang Yi Xue Za Zhi. 2016 Nov 6;50(11):959-965
 Abstract

Disease progression in Chinese patients with hepatitis C virus RNA-positive infection via blood transfusion.
 Pan YF, Zheng Y, Qin T, et al
Exp Ther Med. 2016 Nov;12(5):3476-3484.
 Abstract

An outbreak of HCV genotype 6a and 2a infection in South China: Confirmation of iatrogenic transmission by phylogenetic analysis of the NS5B region.
 Shao X, Luo Q, Cai Q,  et al
Mol Med Rep. 2016 Sep 13.
Abstract

HCV infection status and related risk factors in drug users under HIV sentinel surveillance in Henan province, 2011-2015].
 Li N, Wang XW, Nie YG, et al
Zhonghua Liu Xing Bing Xue Za Zhi. 2016 Jun 10;37(6):821-5.
Abstract

FULL-TEXT ARTICLE
 Will Sofosbuvir/Ledipasvir (Harvoni) Be Cost-Effective and Affordable for Chinese Patients Infected with Hepatitis C Virus? An Economic Analysis Using Real-World Data.
Chen GF, Wei L, Chen J,
PLoS One. 2016 Jun 8;11(6):e0155934.
Paper

A nationwide survey of specialist knowledge on current standard of care (Peg-IFN/RBV) and barriers of care in chronic hepatitis C patients in China.
 Wei L, Li J, Yang X, Wang G, et al
J Gastroenterol Hepatol. 2016 Apr 4.
 Abstract

FULL-TEXT ARTICLE
 Genotype Distribution and Molecular Epidemiology of Hepatitis C Virus in Hubei, Central China.
Peng J, Lu Y, Liu W,  et al
PLoS One. 2015 Sep 1;10(9):e0137059.
 Paper

A review of the burden of hepatitis C virus infection in China, Japan, South Korea and Taiwan.
Bennett H, Waser N, Johnston K, et al
 Hepatol Int. 2015 Jun 13
 Abstract

Hepatitis C virus infection and risk factors in the general population: a large community-based study in eastern China, 2011-2012.
Huang P, Zhu LG, Zhai XJ,  et al
Epidemiol Infect. 2015 Jan 20:1-10.
 Abstract

FULL-TEXT ARTICLE
 Extrahepatic manifestations of chronic hepatitis C virus infection: 297 cases from a tertiary medical center in Beijing, China.
 Cheng Z, Zhou B, Shi X,  et al 
Chin Med J (Engl). 2014 Apr;127(7):1206-10.
 Paper

Association of genetic variants in estrogen receptor α with HCV infection susceptibility and viral clearance in a high-risk Chinese population.
 Tang S, Yue M, Wang J,  et al 
Eur J Clin Microbiol Infect Dis. 2014 Jan 7.
 Abstract

The current HCV prevalence in China may have mainly resulted from an officially encouraged plasma campaign in the 1990s:
a coalescence inference with genetic sequences.
 Lu L, Tong W, Gu L,  et al
J Virol. 2013 Aug 28.
Abstract

Hepatitis C virus infection is independently associated with depression among methadone maintenance treatment heroin users in China.
 Wang Z, Du J, Zhao M,  et al
Asia Pac Psychiatry. 2012 Jul 27
 Abstract

An increased diversity of HCV isolates were characterized among 393 patients with liver disease in China representing six genotypes,
12 subtypes, and two novel genotype 6 variants.
Gu L, Tong W, Yuan M, et al
J Clin Virol. 2013 May 21
 Abstract

Patients younger than forty years old with hepatitis C virus genotype-1 chronic infection had treatment responses similar to
genotype-2 infection and not relatedto interleukin-28B polymorphism.{I-Shyan S, Chun-Yen L, Wen-Juei J, et al 
Ann Hepatol. 2013 Jan;12(1):62-9.
 Abstract

Risk factors for hospitalization and medical intensive care unit (MICU) admission among HIV infected Veterans.
 Akgün KM, Gordon K, Pisani M,  et al
J Acquir Immune Defic Syndr. 2012 Oct 29
 Abstract

FULL-TEXT PARTICLE
High Prevalence of HIV, HCV, HBV and Co-Infection and Associated Risk Factors among Injecting Drug Users in Yunnan Province, China.
 Zhou YH, Yao ZH, Liu FL, et al
PLoS One. 2012;7(8):e42937
 Paper

FULL-TEXT PDF ARTICLE
HIV and HCV prevalence among entrants to methadone maintenance treatment clinics in China: a systematic review and meta-analysis.
Zhuang X, Liang Y, Chow EP, et al
BMC Infect Dis. 2012 Jun 8;12(1):130.
Paper

Simultaneously high prevalence of hepatitis B and C virus infection in a population in Putian County, China.
Lu WP, Lin GX, Shi S, Dong JH.
 J Clin Microbiol. 2012 Mar 7.
 Abstract

FULL-TEXT ARTICLE
 A possible geographic origin of endemic hepatitis C virus 6a in Hong Kong: evidences for the association
with Vietnamese immigration.
Zhou X, Chan PK, Tam JS, Tang JW.
PLoS One. 2011;6(9):e24889.
Paper

FULL-TEXT ARTICLE
 High Prevalence and Genetic Diversity of HCV among HIV-1 Infected People from Various High-Risk Groups in China.
 Shang H, Zhong P, Liu J, et al
PLoS One. 2010 May 27;5(5):e10631.
 Paper
 
      Conference Reports, Abstracts, and Posters
 
  HCV genotype and HBV co-infection associate with HCV clearance in HIV-positive subjects
Y. Dong, C. Qiu, X. Xia, et al
 (XIX International AIDS Conference)
 Abstract

India
 
     Journal Papers, Abstracts, and Commentaries
 
  FULL-TEXT ARTICLE
 Cost-effectiveness of hepatitis C treatment using generic direct-acting antivirals available in India.
 Aggarwal R, Chen Q, Goel A,  et al
PLoS One. 2017 May 17;12(5):e0176503.
 Paper

Correlates of disease-specific knowledge among patients with chronic hepatitis B or hepatitis C infection in India.
 Tamayo A, Shah SR, Bhatia S, et al  
 Hepatol Int. 2016 May 4.
 Abstract

FULL-TEXT ARTICLE
 Origin and Dynamics of HIV-1 Subtype C Infection in India.
Shen C, Craigo J, Ding M, Chen Y, Gupta P. 
PLoS One. 2011;6(10):e25956.
 Paper

Japan
 
     Journal Papers, Abstracts, and Commentaries
 
  HCV Drug Resistance Challenges in Japan: The Role of Pre-Existing Variants and Emerging Resistant Strains in Direct Acting Antiviral Therapy.
Chayama K, Hayes CN.
Viruses. 2015 Oct 13;7(10):5328-5342
 Abstract

FULL-TEXT ARTICLE
 Regional disparities in interferon therapy for chronic hepatitis C in Japan: a nationwide retrospective cohort study
 Masaki N, Yamagiwa Y, Shimbo T,  et al
BMC Public Health. 2015 Jun 19;15:566.
 Paper

A review of the burden of hepatitis C virus infection in China, Japan, South Korea and Taiwan.
 Bennett H, Waser N, Johnston K, et al
Hepatol Int. 2015 Jun 13
 Abstract

IFNL4 ss469415590 Variant Is Associated with Treatment Response in Japanese HCV Genotype 1 Infected Individuals Treated with IFN-Including Regimens.
Miyamura T, Kanda T, Nakamoto S,  et al
 Int J Hepatol. 2014;2014:723868.
Abstract

FULL-TEXT ARTICLE
 Acute Hepatitis C in HIV-1 Infected Japanese Cohort: Single Center Retrospective Cohort Study.
Ishikane M, Watanabe K, Tsukada K,  et al
PLoS One. 2014 Jun 19;9(6):e100517
 Paper

Analysis of the hepatic functional reserve, portal hypertension, and prognosis of patients with human immunodeficiency virus/hepatitis C virus coinfection through contaminated blood products in Japan.
Eguchi S, Takatsuki M, Soyama A,  et al
 Transplant Proc. 2014 Apr;46(3):736-8.
Abstract

FULL-TEXT ARTICLE
 Knowledge of HBV and HCV and Individuals’ Attitudes Toward HBV- and HCV-Infected Colleagues: A National Cross-Sectional Study among a Working Population in Japan
 Eguchi H, Wada K. 
PLoS One. 2013 Sep 26;8(9):e76921
 Paper

FULL-TEXT ARTICLE
 Extrahepatic manifestations and autoantibodies in patients with hepatitis C virus infection.
Himoto T, Masaki T.
Clin Dev Immunol. 2012;2012:871401
 Paper

Korea

      Journal Papers, Abstracts, and Commentaries
 
  FULL-TEXT ARTICLE
Bullous pemphigoid associated with chronic hepatitis C virus infection in a hepatitis B virus endemic area: A case report.[South Korea]
Jang H, Jin YJ, Yoon CH, Kim CW, Kim L.
 Medicine (Baltimore). 2018 Apr;97(15):e0377.
Paper

FULL-TEXT ARTICLE
Estimating the Cost-Effectiveness of One-Time Screening and Treatment for Hepatitis C in Korea.
Kim DY, Han KH, Jun B,
PLoS One. 2017 Jan 6;12(1):e0167770
 Paper

Clinical Features and Outcomes of Patients With Genotype 3 Hepatitis C Virus Infection in Korea: A Retrospective Observational Study.
 Cha RR, Lee SS, Lee CM, et al
Medicine (Baltimore). 2016 Feb;95(6):e2755.
 Abstract

Geographic differences in the epidemiological features of HCV infection in Korea.
Kim KA, Jeong SH, Jang ES,  et al
Clin Mol Hepatol. 2014 Dec;20(4):361-7.
Abstract
 

Myanmar

      Journal Papers, Abstracts, and Commentaries
 

 

Hepatitis C virus genotype distribution in Myanmar: Predominance of genotype 6 and existence of new genotype 6 subtype.
 Lwin AA, Shinji T, Khin M, et al 
 Hepatol Res. 2007 May;37(5):337-45
 Abstract
 
      Conference Reports, Abstracts, and Posters
 
  Prevalence of Hepatitis B and C infections in more than 10000 HIV infected patients in Myanmar
Z. Sai Ko Ko, A. Thet Ko, Y. Moh Moh, et al
(XIX International AIDS Conference)
 Abstract

Nepal
     Journal Papers, Abstracts, and Commentaries

  Social determinants and risk behaviors associated with prevalent Hepatitis C and HIV/HCV co-infection among male injection drug users in Nepal.
Kakchapati S, Maharjan M, Rawal BB, Dixit SM. Arch Public Health. 2017 Sep 4;75:39.
 Abstract
 

Pakistan

      Journal Papers, Abstracts, and Commentaries

  Chronic hepatitis C virus infection and subsequent HIV viral load among women with HIV initiating antiretroviral therapy.
 Willis SJ, Cole SR, Westreich D, et al
AIDS. 2018 Jan 13. 
Abstract

Curbing the hepatitis C virus epidemic in Pakistan: the impact of scaling up treatment and prevention for achieving elimination.
 Lim AG, Qureshi H, Mahmood H,  et al
nt J Epidemiol. 2018 Jan 3.
 Abstract

FULL-TEXT ARTICLE
 A systematic review of treatment response rates in Pakistani hepatitis C virus patients; current prospects and future challenges.
 Ali M, Afzal S, Zia A, Hassan A, et al
 Medicine (Baltimore). 2016 Dec;95(50):e5327.
 Paper

Thyroid Peroxidase Antibodies in Non-Interferon Treated Hepatitis C Patients in Pakistan.
Shafiq MI, Gauhar A, Akram M, Elahi S.
Biomed Res Int. 2015;2015:172981
 Abstract

Genetic History of Hepatitis C Virus in Pakistan.
Rehman IU, Vaughan G, Purdy MA,  et al
 Infect Genet Evol. 2014 Aug 12.
 Abstract

Determination of HCV genotypes and viral loads in chronic HCV infected patients of Hazara Pakistan.
Ali A, Nisar M, Ahmad H, Saif N,
Virol J. 2011 Oct 9;8(1):466
 Abstract
 

Singapore

      Journal Papers, Abstracts, and Commentaries
 
  FULL TEXT PDF ARTICLE
Seroprevalence of hepatitis C in intravenous opioid users presenting in the early phase of injecting drug use in Singapore.
Winslow M, Subramaniam M, Ng WL, et al
Singapore Med J. 2007 Jun;48(6):504-8.
 Paper
 
Taiwan

      Journal Papers, Abstracts, and Commentaries
 
  FULL-TEXT ARTICLE
The characteristics of residents with unawareness of hepatitis C virus infection in community.
Cheng PN, Chiu YC, Chiu HC, Chien SC.
PLoS One. 2018 Feb 22;13(2):e0193251.
 Paper

Sexual Dimorphic Metabolic Alterations in Hepatitis C Virus-infected Patients: A Community-Based Study in a Hepatitis B/Hepatitis C Virus Hyperendemic Area.
 Hu JH, Chen MY, Yeh CT, et al
Medicine (Baltimore). 2016 May;95(18):e3546.
 Abstract

FULL-TEXT ARTICLE
Increasing incidence of recent hepatitis C virus infection among persons seeking voluntary counselling and testing for HIV and sexually transmitted infections in Taiwan.
 Tsai JC, Hung CC, Chang SY,  et al
BMJ Open. 2015 Oct 13;5(10):e008406.
Paper

A review of the burden of hepatitis C virus infection in China, Japan, South Korea and Taiwan.
 Bennett H, Waser N, Johnston K, et al
 Hepatol Int. 2015 Jun 13
 Abstract

Association between IPTA Gene Polymorphisms and Hematological Abnormalities in Hepatitis C Virus-Infected Patients Receiving Combination Therapy.
 Hwang JJ, Lo CC, Lin CH,  et al 
Gut Liver. 2014 Oct 7.
Abstract
 

Thailand

      Journal Papers, Abstracts, and Commentaries
 
  FULL-TEXT ARTICLE
 Decreasing Hepatitis C Virus Infection in Thailand in the Past Decade: Evidence from the 2014 National Survey.
 Wasitthankasem R, Posuwan N, Vichaiwattana P, et al  
PLoS One. 2016 Feb 12;11(2):e0149362
 Paper
 

Taiwan

      Journal Papers, Abstracts, and Commentaries
 
  Relation Between Hepatitis C Virus Exposure and Risk of Osteoporosis: A Nationwide Population-Based Study.
Chen CH, Lin CL, Kao CH. 
Medicine (Baltimore). 2015 Nov;94(47):e2086
 Abstract

Vietnam

      Journal Papers, Abstracts, and Commentaries
 
  FULL-TEXT ARTICLE
 Treatment of hepatitis C as prevention: a modeling case study in Vietnam.
Durier N, Nguyen C, White LJ.
PLoS One. 2012;7(4):e34548.
 Paper
Australia/Pacific Islands
 
Australia

   Journal Papers, Abstracts, and Commentaries
 
 
Uptake of and Expenditure on Direct-Acting Antiviral Agents for Hepatitis C Treatment in Australia.
 de Graaff B, Yee KC, Clarke P, Palmer A.
 Appl Health Econ Health Policy. 2018 Apr 19.
Abstract

Implementation of hepatitis C cure in Australia: one year on.
Richmond JA, Wallace J.   
 J Virus Erad. 2018 Apr 1;4(2):115-117.
 Abstract

‘Beyond the willing & the waiting’ – The role of peer-based approaches in hepatitis C diagnosis & treatment. [Australia]
 Henderson C, Madden A, Kelsall J.
 Int J Drug Policy. 2017 Sep 15
 Abstract

Clinical effectiveness, cost-effectiveness and acceptability of community-based management of chronic hepatitis C: a mixed methods systematic review protocol. Australia)
Pourmarzi D, Hall L, Rahman T, Lim D, FitzGerald G.
 JBI Database System Rev Implement Rep. 2017 Apr;15(4):914-931
 Abstract

HCV reinfection incidence among individuals treated for recent infection.
 Martinello M, Grebely J, Petoumenos K,
J Viral Hepat. 2016 Dec 27.
 Abstract

The effects of needle-sharing and opioid substitution therapy on incidence of hepatitis C virus infection and reinfection in people who inject drugs.
 Aitken CK, Agius PA, Higgs PG, et al
Epidemiol Infect. 2016 Dec 8:1-6
 Abstract

Limited provision of diagnostic services to Victorians living with hepatitis C antibodies, 2001-2012: a multi-level modelling analysis.
Snow K, Scott N, Clothier HJ, ET AL
 Aust N Z J Public Health. 2016 Aug 14.
Abstract

HCV knowledge among a sample of HCV positive Aboriginal Australians residing in New South Wales.
 Wilson H, Brener L, Jackson LC, et al  
Psychol Health Med. 2016 Jun 7:1-8.
 Abstract

Chronic hepatitis C burden and care cascade in Australia in the era of interferon-based treatment.
 Hajarizadeh B, Grebely J, McManus H,  et al
J Gastroenterol Hepatol. 2016 May 19.
Abstract

Australian recommendations for the management of hepatitis C virus infection: a consensus statement.
 Thompson AJ. 
Med J Aust. 2016 Apr 18;204(7):268-72.
 Abstract

Regional challenges: evaluation of a hepatitis outreach program using transient elastography (FibroScan® ) in Victoria.
Thurnheer MC, Schulz TR, Nguyen T, MacLachlan J, Sasadeusz J.
 Intern Med J. 2015 Nov 25.
Abstract

Experiences of diagnosis, care and treatment among Aboriginal people living with hepatitis C.
Brener L, Wilson H, Jackson LC,   et al 
Aust N Z J Public Health. 2015 Jun 29.
 Abstract

The effect of social functioning and living arrangement on treatment intent, specialist assessment and treatment uptake for hepatitis C virus infection among people with a history of injecting drug use: The ETHOS study.
Fortier E, Alavi M, Micallef M,  et al 
Int J Drug Policy. 2015 Jun 11
 Abstract

Effect of treatment willingness on specialist assessment and treatment uptake for hepatitis C virus infection among people who use drugs: the ETHOS study.
Alavi M, Micallef M, Fortier E,  et al
J Viral Hepat. 2015 May 21
 Abstract

FULL-TEXT ARTICLE
 Hepatitis C polymerase chain reaction testing by GPs.
 Bailey S, Scalley B, Gilles M. 
Aust Fam Physician. 2015;44(1):69-70..
 Paper

Care and treatment of hepatitis C among Aboriginal people in New South Wales, Australia: implications for the implementation of new treatments.
Treloar C, Jackson C, Gray R, et al
Ethn Health. 2015 Feb 10:1-19
 Abstract

Opioid substitution therapy is associated with increased detection of hepatitis C virus infection: A 15-year observational cohort study.
Larney S, Grebely J, Falster M, et al
 Drug Alcohol Depend. 2015 Jan 5. pii: S0376-8716(14)02007-9
 Abstract

Equity in primary health care delivery: an examination of the cohesiveness of strategies relating to the primary healthcare system, the health workforce and hepatitis C.[Austraiia}
 Scarborough J, Eliott J, Miller E, Aylward P.
 Aust Health Rev. 2014 Dec 11
 Abstract

Delivery of treatment for hepatitis C virus infection in the primary care setting.
Baker D, Alavi M, Erratt A, et al
 Eur J Gastroenterol Hepatol. 2014 Jul 19
 Abstract

Discrimination by health care workers versus discrimination by others: Countervailing forces on HCV treatment intentions.
Brener L, Horwitz R, von Hippel C, et al
Psychol Health Med. 2014 Jun 3:1-6
 Abstract

A piece of the jigsaw of primary care: health professional perceptions of an integrated care model of hepatitis C management in the community.
Treloar C, Gray R, Brener L.
J Prim Health Care. 2014 Jun 1;6(2):129-34.
 Abstract

Under the watchful eye of ‘a benevolent dictator’ – General practitioner and patient experiences of hepatitis C treatment initiation and
shared-care in general practice.
Hopwood M, Treloar C.
Aust Fam Physician. 2013 Dec;42(12):900-3.
 Abstract

Barriers and facilitators for assessment and treatment of hepatitis C virus infection in the opioid substitution treatment setting: insights from the ETHOS study.
Treloar C, Rance J, Dore GJ, Grebely J.
 J Viral Hepat. 2013 Dec 3.
 Abstract

Understanding barriers to hepatitis C virus care and stigmatization from a social perspective.
 Treloar C, Rance J, Backmund M.
Clin Infect Dis. 2013 Aug;57 Suppl 2:S51-5.
Abstract

Correlates and characteristics of hepatitis C virus-specific T-cell immunity in exposed uninfected high-risk prison inmates.
Cameron B, Galbraith S, Li H,  et al
J Viral Hepat. 2013 Apr;20(4):e96-e106.
Abstract

Safety and Effectiveness of a Nurse-Led Outreach Program for Assessment and Treatment of Chronic Hepatitis C in the Custodial Setting.
Lloyd AR, Clegg J, Lange J, , Monkley D. et al 
Clin Infect Dis. 2013 Jan 29
 Abstract

Hepatitis C virus reinfection and superinfection among treated and untreated participants with recent infection.
 Grebely J, Pham ST, Matthews GV, et al
Hepatology. 2011 Oct 26.
Abstract

Structural constraints on the training of peer educators in hepatitis C prevention.
Treloar C, Rance J, Laybutt B, Crawford S
Health Educ Res. 2011 Oct 10.
 Abstract

A systematic review of hepatitis C virus epidemiology in Asia, Australia and Egypt.
 Sievert W, Altraif I, Razavi HA, et al
Liver Int. 2011 Jul;31 Suppl 2:61-80.
Abstract
Middle East
 		      
Regional/Multinational
 
          Journal Papers, Abstracts, and Commentaries
 
  Prevalence of hepatitis C virus infection among hemodialysis patients in the Middle-East: A systematic review and meta-analysis.
 Ashkani-Esfahani S, Alavian SM, Salehi-Marzijarani M.
 World J Gastroenterol. 2017 Jan 7;23(1):151-166.
 Abstract

FULL-TEXT ARTICLE
 The Epidemiology of Hepatitis C Virus in the Fertile Crescent: Systematic Review and Meta-Analysis.
 Chemaitelly H, Chaabna K, Abu-Raddad LJ.
 PLoS One. 2015 Aug 21;10(8):e0135281.
Paper

FULL-TEXT ARTICLE
 Epidemiology of hepatitis C in the middle east.
 Fallahian F, Najafi A.
Saudi J Kidney Dis Transpl. 2011 Jan-Feb;22(1):1-9.
 Paper

Afghanistan
 
          Journal Papers, Abstracts, and Commentaries
 
  Hepatitis C and HIV incidence and harm reduction program use in a conflict setting: an observational cohort of injecting drug users in Kabul, Afghanistan.
Todd CS, Nasir A, Stanekzai MR, et al
Harm Reduct J. 2015 Oct 16;12(1):22.
Abstract
 
Bahrain.

 
          Journal Papers, Abstracts, and Commentaries
 
  Interrelationship of hepatitis C virus genotypes with patient characteristics in Bahrain.
 Abdulla MA, Murad EA, Aljenaidi HA, 35 al
 Hepat Med. 2017 Mar 1;9:7-11
 Abstract
 

Iran

           Journal Papers, Abstracts, and Commentaries
 
 
The prevalence of hepatitis C virus infection in thalassemia patients in Iran from 2000 to 2017: a systematic review and meta-analysis.
Behzadifar M, Gorji HA, Bragazzi NL.
 Arch Virol. 2018 Feb 6.
 Abstract

The epidemiology of hepatitis C virus in Iran: Systematic review and meta-analyses.
 Mahmud S, Akbarzadeh V, Abu-Raddad LJ.
 Sci Rep. 2018 Jan 9;8(1):150
 Abstract

FULL-TEXT ARTICLE
 Epidemic History of Hepatitis C Virus among Patients with Inherited Bleeding Disorders in Iran.
 Samimi-Rad K, Rahimnia R, Sadeghi M, et al 
PLoS One. 2016 Sep 9;11(9):e0162492.
Paper

The treatment of HCV in patients with haemoglobinopathy in Kurdistan Region, Iraq: a single centre experience.
Hussein NR, Tunjel I, Basharat Z,  et al
 Epidemiol Infect. 2016 Jun;144(8):1634-40.
Abstract

High HCV prevalence among drug users in Iran: Systematic review and meta-analysis of epidemiological evidence (2001-2012).
 Malekinejad M, Navadeh S, Lotfizadeh A, et al
 Int J Infect Dis. 2015 Oct 9.
 Abstract

FULL-TEXT PDF ARTICLE
 Burden of Hepatitis C in Iran Between 1990 and 2010:
 Mohaghegh Shalmani H, Noori A, et al
Arch Iran Med. 2015 Aug;18(8):508-14
 Paper

The Impact of IFN-γ Gene Polymorphisms on Spontaneous Clearance of HCV Infection in Fars Province, Southern of Iran.
 Sarvari J, Moattari A, Pirbonyeh N,et al
J Clin Lab Anal. 2015 May 20.
Abstract

Genotyping Pattern among Iranian HCV Positive Patients.
Hajia M, Amirzargar A, Khedmat H,
Iran J Public Health. 2010;39(2):39-44
 Abstract

Seroprevalence of hepatitis C virus: the first population-based study from Iran.
 Merat S, Rezvan H, Nouraie M, Jafari E,  
Int J Infect Dis. 2010 Mar 31.
 Abstract

 
Iraq
 
          Journal Papers, Abstracts, and Commentaries
 
  Prevalence of hepatitis B and C among blood donors attending the National Blood Transfusion Center in Baghdad, Iraq from 2006-2009.
Ataallah TM, Hanan KA, Maysoun KS, Sadoon AA
Saudi Med J. 2011 Oct;32(10):1046-50.
 Abstract

Israel
          Journal Papers, Abstracts, and Commentaries
 
  Epidemiology of hepatitis C virus infection in a large Israeli health maintenance organization.
 Weil C, Nwankwo C, Friedman M,  et al 
J Med Virol. 2016 Jun;88(6):1044-50.
Abstract

A systematic review of hepatitis C virus epidemiology in Europe, Canada and Israel.
 Cornberg M, Razavi HA, Alberti A, et al
 Liver Int. 2011 Jul;31 Suppl 2:30-60.
Abstract

Pakistan

          Journal Papers, Abstracts, and Commentaries

 
Molecular epidemiology of hepatitis C virus genotypes in different geographical regions of Punjab Province in Pakistan and a phylogenetic analysis.
Aziz H, Raza A, Murtaza S, et al
Int J Infect Dis. 2012 Nov 22.
 Abstract

Saudi Arabia

          Journal Papers, Abstracts, and Commentaries

 
FULL-TEXT ARTICLE
Molecular characterization and epidemic history of hepatitis C virus using core sequences of isolates from Central Province, Saudi Arabia.
Shier MK, Iles JC, El-Wetidy MS, Ali HH, Al Qattan MM.
 PLoS One. 2017 Sep 1;12(9):e0184163
 Paper

Epidemiology, disease burden, and treatment strategies of chronic hepatitis C virus infections in Saudi Arabia in the new treatment paradigm shift.
 Aljumah AA, Abaalkhail F, Al-Ashgar H, et al  
 Saudi J Gastroenterol. 2016 Jul-Aug;22(4):269-81
 Abstract
Russia/New Independent States
 		      
Russia
 
        Journal Papers, Abstracts, and Commentaries
 
  The problem of viral hepatitis C in the Russian Federation
[No authors listed]
 Ter Arkh. 2014;86(10):77-81
 Abstract

FULL-TEXT ARTICLE
Hepatitis C virus seroprevalence among people who inject drugs and factors associated with infection in eight Russian cities.
 Heimer R, Eritsyan K, Barbour R, Levina OS. 
BMC Infect Dis. 2014 Sep 19;14(Suppl 6):S12.
 Paper

 

HCV Main Page Main New/Newsworthy  Home Page      

National Seroprevalence/Incidence Studies
National Challenges